Colgate-Palmolive Company (CL) Financial Statements
Colgate-Palmolive Company (CL) reported trailing twelve-month revenue of $21.0B (up 5.2% year on year) and net income of $2.0B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $3.9B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLColgate-Palmolive CompanyFollow CL — free
—
Price chart with a free account
- Market cap
- 75.0B
- P/E TTM
- 37.2
- Dividend yield
- 2.2%
- 52-week
- —
- Next earnings
- 30 Oct, in 6 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.33 | 15.56 | 16.73 | 17.09 | 17.42 | 17.28 | 16.03 | 15.20 | 15.45 | 15.54 | 15.69 | 16.47 | 17.42 | 17.97 | 19.46 | 20.10 | 20.38 | 21.05 | |
| Gross profit | 9.01 | 9.20 | 9.59 | 9.93 | 10.20 | 10.11 | 9.40 | 9.12 | 9.28 | 9.23 | 9.33 | 10.02 | 10.38 | 10.25 | 11.33 | 12.16 | 12.25 | 12.72 | |
| Research & development | — | 0.26 | 0.26 | 0.26 | 0.27 | 0.28 | 0.27 | 0.29 | 0.29 | 0.28 | 0.28 | 0.29 | 0.31 | 0.32 | 0.34 | 0.36 | 0.37 | — | |
| Operating income | 3.62 | 3.49 | 3.84 | 3.89 | 3.56 | 3.56 | 2.79 | 3.96 | 3.71 | 3.69 | 3.55 | 3.89 | 3.33 | 2.89 | 3.98 | 4.27 | 3.31 | 3.13 | |
| Pre-tax income | 3.54 | 3.43 | 3.79 | 3.87 | 3.57 | 3.53 | 2.76 | 3.74 | 3.49 | 3.46 | 3.30 | 3.65 | 3.09 | 2.66 | 3.39 | 3.96 | 3.06 | 2.94 | |
| Income tax | 1.14 | 1.12 | 1.24 | 1.24 | 1.16 | 1.19 | 1.22 | 1.15 | 1.31 | 0.91 | 0.77 | 0.79 | 0.75 | 0.69 | 0.94 | 0.91 | 0.80 | 0.78 | |
| Net income | 2.29 | 2.20 | 2.43 | 2.47 | 2.24 | 2.18 | 1.38 | 2.44 | 2.02 | 2.40 | 2.37 | 2.70 | 2.17 | 1.79 | 2.30 | 2.89 | 2.13 | 2.04 | |
| Diluted EPS ($) | 4.37 | 4.31 | 2.47 | 2.57 | 2.38 | 2.36 | 1.52 | 2.72 | 2.28 | 2.75 | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 | 2.53 | |
| Diluted shares (bn) | — | 0.511 | 0.984 | 0.960 | 0.940 | 0.924 | 0.910 | 0.898 | 0.888 | 0.873 | 0.861 | 0.859 | 0.848 | 0.839 | 0.829 | 0.823 | 0.811 | — |
USD billions · SEC XBRL
Colgate-Palmolive Company — questions
- What is Colgate-Palmolive Company's revenue?
- $21.0B over the twelve months to 2026-06-30, up 5.2% year on year, from its 10-Q and 10-K filings.
- What is Colgate-Palmolive Company's net income?
- $2.0B over the twelve months to 2026-06-30.
- What is Colgate-Palmolive Company's free cash flow?
- $3.9B over the twelve months to 2026-06-30.
- What are Colgate-Palmolive Company's diluted earnings per share?
- $2.53 over the twelve months to 2026-06-30.
Every figure on this page comes from Colgate-Palmolive Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.